Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: News

Laigo Bio completes final close of €17m seed financing round

Laigo Bio completes final close of €17m seed financing round
p p Read More

Laigo Bio has completed the second close of its seed financing round at €5.5m, bringing the total raised […]

March 26, 2026 News

Axplora announces expansion as newest part of $60m API investment programme

Axplora announces expansion as newest part of m API investment programme
p p Read More

Axplora has announced plans to build a 4,500sqm R&D and laboratory hub at its Farmabios site in Gropello […]

March 25, 2026 News

DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream

DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
p p Read More

DNA Script has signed distribution agreements with Gencell, Bio-Medical Science (BMS) and Biostream, expanding global access to its […]

March 24, 2026 News

Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone

Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
p p Read More

Ondine Biomedical has announced the North American phase 3 study has reached more than 93% enrolment, bringing the […]

March 23, 2026 News

Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease

Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
p p Read More

Early trial shows more than 50% LRRK2 reduction and supports expansion into other neurodegenerative conditions

March 19, 2026 News

Alzecure shares new preclinical data on NeuroRestore ACD856 at AD/PD conference

Alzecure shares new preclinical data on NeuroRestore ACD856 at AD/PD conference
p p Read More

Lead Alzheimer’s candidate shows clear biological effects and antidepressant potential

March 19, 2026 News

Samsung Bioepis signs partnership with Sandoz for next‑generation biosimilars

Samsung Bioepis signs partnership with Sandoz for next‑generation biosimilars
p p Read More

Deal covers up to five candidates including SB36 as company expands global pipeline

March 18, 2026 News

Atrogi begins dosing first subjects in human trial of ATR-258

Atrogi begins dosing first subjects in human trial of ATR-258
p p Read More

Study to explore mechanism behind novel oral therapy for muscle‑sparing weight loss

March 18, 2026 News

R1 Therapeutics launches with $77.5m to advance hyperphosphatemia treatment

R1 Therapeutics launches with .5m to advance hyperphosphatemia treatment
p p Read More

Financing and global licensing deal to accelerate phase 2b development of AP306

March 17, 2026 News

Taiwan Bio partners with Terumo to advance automated Treg manufacturing

Taiwan Bio partners with Terumo to advance automated Treg manufacturing
p p Read More

Collaboration aims to streamline and scale next‑generation Treg therapy production

March 17, 2026 News

Posts navigation

Posts pagination

« Previous 1 2 3 … 85 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy